![]() |
|||||||||||||
|
All | Since 2019 | |
Citation | 5450 | 3969 |
h-index | 23 | 20 |
i10-index | 134 | 84 |
ORCIPRENALINE & HYOSCINE BUTYLBROMIDE – POOR MAN’S PACE MAKER - A SHORT CASE REVIEW STUDY
Dr. Mayank Chugh*, Dr. Satender Tanwar and Dr. Shree Parkash
ABSTRACT Bradycardia are a common clinical finding and comprise a number of rhythm disorders including SA Node dysfunction and AV conduction disturbances. Clinical presentation varies from asymptomatic electrocardiogram findings (eg, during a routine examination) to a wide range of symptoms such as heart failure symptoms, near syncope or syncope, central nervous symptoms, or nonspecific and chronic symptoms such as dizziness or fatigue. Conditions resulting in brady arrhythmic disorders are divided into intrinsic and extrinsic conditions causing damage to the conduction system. Furthermore brady arrhythmias can be a normal physiologic reaction under certain circumstances. A proper diagnosis including a symptom-rhythm correlation is extremely important and is generally established by noninvasive diagnostic studies (12-lead electrocardiogram, Holter electrocardiogram, exercise testing, event recorder, implantable loop recorder). Invasive electro physiologic testing is rarely required. If reversible extrinsic causes of brady arrhythmias such as drugs (most often beta-blockers, glycosides and/or calcium channel blockers) or underlying treatable diseases are ruled out, cardiac pacing is usually the therapy of choice in symptomatic brady arrhythmias. In this article of the current series on arrhythmias we will review the pathophysiology, diagnosis and treatment options of brady arrhythmias, especially sinus node dysfunction and atrio ventricular conduction blocks.[1] Keywords: . [Download Article] [Download Certifiate] |